Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NUCYNTA vs Oxycodone IR in Acute Low Back Pain
NCT00986180Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tapentadol in acute low back pain (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Sum of Pain Intensity Difference at 120 Hours. Started Sep 2009; status: completed.
02
Drugs
tapentadol
03
Conditions
acute low back pain
Beyond the preview
Go deeper on NCT00986180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00986180.